Vyvanse Capsules 30mg from Takeda Pharmaceutical contain lisdexamfetamine mesylate, a CNS stimulant indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in adults and children 6 years and older, and moderate to severe binge eating disorder in adults. The YJ code is 1179059M2020, with a standard of 30mg per capsule.
Vyvanse Capsules 30mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
